Observational studyMedicine2026
Effect of endometrioma size and bilaterality on clinical, surgical, and laboratory parameters in endometriosis: A retrospective study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometriosis is a chronic inflammatory disease that can cause many problems such as dipmenorrhea, dyspareunia, pelvic pain, and infertility. The aim of this study was to investigate the clinical, demographic, and laboratory characteristics that are primarily considered in the management of patients with endometrioma, focusing on the effects of cyst size and laterality. This study included 210 patients aged 18 to 50 who underwent endometrioma surgery. Demographic characteristics, infertility histories, surgical procedures, antral follicle counts, and laboratory parameters (CA-125, follicle stimulating hormone, anti-Müllerian hormone [AMH], and estradiol) of the patients were compared by classifying them according to endometrioma size and bilaterality. Endometrioma size was classified as ≤30, >30 to ≤50, >50 to ≤70, and >70 mm. This was a retrospective, observational study. No significant differences in age or reproductive history, including gravida and parity, were observed between groups. However, body mass index was significantly lower in the >70 mm group. Additionally, the rates of pelvic pain and infertility were higher in patients with bilaterality or larger endometriomas (P = .022, P = .029). The >70 mm and with bilaterality group had the lowest preoperative AMH levels and the highest CA-125 levels compared to the ≤30 mm and without bilaterality group (P = .009, P = .008). To improve statistical robustness, an additional literature-based stratification using a 50 mm cutoff and bilaterality was applied, and further comparative and regression analyses were performed. In the logistic regression analysis, Low AMH levels were independently associated with the presence of large (>50 mm) and bilateral endometriomas (odds ratio = 0.12, 95% confidence interval [CI]: 0.04-0.41; P = .002). In conclusion, larger and bilateral endometriomas tend to be associated with lower AMH levels, and further research aimed at better elucidating the underlying mechanisms of this relationship is needed to help resolve existing inconsistencies in the literature.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.